FENNEC PHARMACEUTICALS INC.·4

Jun 10, 5:27 PM ET

Cook Jodi A 4

4 · FENNEC PHARMACEUTICALS INC. · Filed Jun 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Fennec Pharmaceuticals Director Jodi Cook Receives Option Award

What Happened
Jodi A. Cook, a director of Fennec Pharmaceuticals, was granted a non‑qualified stock option to acquire 20,000 shares on June 10, 2026. The option strike price is $8.70 per share (20,000 × $8.70 = $174,000 reported value). This filing reports an award (derivative grant), not a purchase or sale of underlying shares.

Key Details

  • Transaction date: 2026-06-10; transaction type: A (award/grant of derivative).
  • Grant: 20,000 stock options with exercise price $8.70; reported aggregate value $174,000.
  • Vesting: 100% vested on grant (per footnote). Options can be exercised immediately, but no exercise or sale is reported.
  • Shares owned after transaction: Not specified in this filing.
  • Timeliness: Filing dated 2026-06-10 (same date as transaction), so not indicated as late.

Context
A non‑qualified stock option is a compensation award that gives the holder the right to buy common shares at the stated strike ($8.70). Until exercised, the award is a derivative — it does not represent current share ownership or a market purchase. Grants are routine compensation for executives/directors and do not by themselves indicate buying/selling of stock.

Insider Transaction Report

Form 4
Period: 2026-06-10
Cook Jodi A
Director
Transactions
  • Award

    Stock Options

    [F1][F2]
    2026-06-10$8.70/sh+20,000$174,000160,000 total
    Exercise: $8.70From: 2026-06-10Exp: 2036-06-10Common Shares (20,000 underlying)
Footnotes (2)
  • [F1]On June 10, 2026, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
  • [F2]The option is 100% vested on date of grant.
Signature
/s/ Jodi Cook|2026-06-10

Documents

1 file
  • 4
    form4-06102026_090632.xmlPrimary